Lewes, DE -- (SBWIRE) -- 07/24/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Federal Home Loan Mortgage Corp (OTCBB:FMCC), Liquidmetal Technologies Inc (OTCBB:LQMT), Invivo Therapeutics Holdings Corp (OTCBB:NVIV), Fairfax Financial Holdings Ltd p (OTCMKTS:FRFHF)
Federal Home Loan Mortgage Corp (OTCBB:FMCC) declined -1.36%, trading on 11.10 million shares to end the trade at $1.45. The stock changed hands in a range of $1.45 to $1.57, bringing its market capitalization at about $942.56 million. If we look at its trading history of past 52 weeks, the share price suffered low of $0.14 and was moved to maximum level of $5.00. Federal Home Loan Mortgage Corporation provides credit guarantee for residential mortgages originated by mortgage lenders and invests in mortgage loans and mortgage-related securities in the United States.
Will FMCC Get Buyers Even After The Recent Rally? Find Out Here
Liquidmetal Technologies Inc (OTCBB:LQMT) declined -0.99% to complete the trading session at $0.180 with a total volume of 39.47 million shares. The stock, on average, trades on a volume of 11.42 million shares. It floated in a range of $0.18 to $0.23 during last trading session with a beta value of 1.58. Its market capitalization now moved to about $46.12 million. In the past 52 weeks, the share price has not declined below $0.05 and above $0.33. Liquidmetal Technologies, Inc., a materials technology company, designs, develops, and sells products and components from bulk amorphous alloys worldwide. The company offers components for non-consumer electronic devices, including parts for high end printers, commercial imaging devices, aerospace and defense components, medical devices, automotive components, and industrial machines.
Will LQMT Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Invivo Therapeutics Holdings Corp (OTCBB:NVIV) recorded a fall of -2.12% and was in a range of $5.52-$5.94 before closing at $5.55. The stock completed the day with a total volume of 728,634 shares versus an average volume of 484,970 shares. The share price hit its 52-week low of $1.25 and $6.20 was the best price. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Is it the Right to Grab NVIV after the Recent Slump? Get Free Trend Analysis Here
Fairfax Financial Holdings Ltd (OTCMKTS:FRFHF) declined -0.28% yesterday, bringing its market capitalization around $34.38 billion. The share price after opening at $405.49 made a high of $408.60 and hovered above $405.41 to end the day at $407.01. The total number of shares changed hands during the session was 5,852 shares as compared to average trading volume of 7,372 shares. Fairfax Financial Holdings Limited, through its subsidiaries, provides property and casualty insurance products in the United States, Canada, and internationally.
Will FRFHF Reach the Bottom after Yesterday’s Correction? Find Out Here
About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/